Cargando…

A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation

Multiple sclerosis is a neuroinflammatory degenerative disease, caused by activated immune cells infiltrating the CNS. The disease etiology involves both genetic and environmental factors. The mouse genetic locus, Eae27, linked to disease development in the experimental autoimmune encephalomyelitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobsen, Freja Aksel, Scherer, Alexander N., Mouritsen, Jeppe, Bragadóttir, Hera, Thomas Bäckström, B., Sardar, Samra, Holmberg, Dan, Koleske, Anthony J., Andersson, Åsa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928183/ https://www.ncbi.nlm.nih.gov/pubmed/29550892 http://dx.doi.org/10.1007/s11481-018-9783-8

Ejemplares similares

Arg Deficiency Does not Influence the Course of Myelin Oligodendrocyte Glycoprotein (MOG35-55)-induced Experimental Autoimmune Encephalomyelitis
por: Jacobsen, Freja Aksel, et al.
Publicado: (2016)

Regulation of Actin Polymerization and Adhesion-Dependent Cell Edge Protrusion by the Abl-Related Gene (Arg) Tyrosine Kinase and N-WASp
por: Miller, Matthew M., et al.
Publicado: (2010)

Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo
por: Gil-Henn, Hava, et al.
Publicado: (2012)

The Abl-related gene (Arg) requires its F-actin–microtubule cross-linking activity to regulate lamellipodial dynamics during fibroblast adhesion
por: Miller, Ann L., et al.
Publicado: (2004)

Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases
por: Dong, Qincai, et al.
Publicado: (2017)

Regulation of MT dynamics via direct binding of an Abl family kinase
por: Hu, Yuhan, et al.
Publicado: (2019)

Constitutive Activity in an Ancestral Form of Abl Tyrosine Kinase
por: Aleem, Saadat U., et al.
Publicado: (2015)

Bcr-Abl tyrosine kinase inhibitors- current status
por: Mughal, Anum, et al.
Publicado: (2013)

Tyrosine kinase c-Abl regulates the survival of plasma cells
por: Li, Yan-Feng, et al.
Publicado: (2017)

Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry
por: Min, Saehong, et al.
Publicado: (2017)

Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML
por: Carofiglio, Francesca, et al.
Publicado: (2020)

The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies
por: Motaln, Helena, et al.
Publicado: (2023)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
por: Takeuchi, Asako, et al.
Publicado: (2020)

Analysis of Polymorphisms in the Mediator Complex Subunit 13-like (Med13L) Gene in the Context of Immune Function and Development of Experimental Arthritis
por: Sardar, Samra, et al.
Publicado: (2018)

A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M, et al.
Publicado: (2006)

Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade
por: Luttman, Jillian Hattaway, et al.
Publicado: (2021)

Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection
por: Ullah, Imran, et al.
Publicado: (2023)

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
por: Bieerkehazhi, Shayahati, et al.
Publicado: (2016)

Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase
por: Imam, Syed Z., et al.
Publicado: (2007)

Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
por: Mesa, Ruben A
Publicado: (2007)

Cbl-associated protein is tyrosine phosphorylated by c-Abl and c-Src kinases
por: Fernow, Inga, et al.
Publicado: (2009)

BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
por: Cuellar, Sandra, et al.
Publicado: (2017)

c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution
por: Badger, John, et al.
Publicado: (2016)

RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
por: He, Fang, et al.
Publicado: (2021)

c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth
por: Chandía-Cristi, América, et al.
Publicado: (2023)

Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M., et al.
Publicado: (2012)

Abl Tyrosine Kinase Phosphorylates Nonmuscle Myosin Light Chain Kinase to Regulate Endothelial Barrier Function
por: Dudek, Steven M., et al.
Publicado: (2010)

Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage
por: Nehmé, A, et al.
Publicado: (2000)

cGMP-mediated antioxidant signaling: a role for the c-Abl tyrosine kinase
por: Stephens, Robert S, et al.
Publicado: (2011)

Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
por: de Almeida, Maria Helena, et al.
Publicado: (2014)

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
por: Rassi, Fuad El, et al.
Publicado: (2013)

Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase
por: Reckel, Sina, et al.
Publicado: (2017)

Interaction of Abl Tyrosine Kinases with SOCS3 Impairs Its Suppressor Function in Tumorigenesis()()()
por: Feng, Riyue, et al.
Publicado: (2018)

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?
por: Haguet, Hélène, et al.
Publicado: (2018)

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
por: Stanchina, Michele, et al.
Publicado: (2020)

Dynamic morphogenesis of a pioneer axon in Drosophila and its regulation by Abl tyrosine kinase
por: Clarke, Akanni, et al.
Publicado: (2020)

Corrigendum: RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
por: He, Fang, et al.
Publicado: (2021)

BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro
por: Kauer, Joseph, et al.
Publicado: (2022)

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease
por: León, Rilda, et al.
Publicado: (2023)

Arg interacts with cortactin to promote adhesion-dependent cell edge protrusion
por: Lapetina, Stefanie, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bhtkakt7l0h0cb268iid3id8er